Tobacco is known to cause cancer and heart diseases. Per media sources, it causes more than 480,000 deaths annually in the United States. Governments around the world have been imposing stringent restrictions on tobacco companies to lower cigarette consumption. In July 2017, the U.S. Food and Drug Administration (FDA) proposed to lower nicotine levels in cigarettes, as tar and other substances inhaled through smoking is detrimental to health.

Not only this, the FDA has made it mandatory for tobacco companies to use precautionary labels on cigarette packets to dissuade customers from smoking. The European Union and the FDA have proposed a ban on menthol in accordance with the Tobacco Control Act. Per the act, menthol has an adverse effect on health and thus should not be used in any product.

Amid increasing government restrictions and declining smoking rates, the tobacco giants have introduced e-cigarettes and Reduced Risk Products to mitigate losses. However, the FDA also imposed several restrictions on e-cigarettes.

The FDA made it mandatory for all tobacco makers to seek marketing authorization for any tobacco product introduced after Feb 15, 2007. The law was extended to include e-cigarettes, pipe tobacco, cigars and hookah. The FDA has currently deferred its reviews for products like cigars and hookah tobacco until 2021 and e-cigarettes until 2022.

Share Price Performance: Industry Versus S&P 500

Given the aforementioned turmoil, it is not at all surprising that the Zacks Tobacco industry is currently placed at the bottom 36% out of the 265 Zacks Industries. The industry has slumped 3.9% in the last six months, against the S&P 500 market’s 4.6% growth.

4 High-Yield Tobacco Picks Despite Industry Woes

Despite these factors investing in tobacco stocks can be a wise decision. Historically, these stocks have maintained earnings growth consistently by trimming expenses and undertaking judicious mergers and acquisitions.